Ispecimen INC. 8-K Filing
Ticker: ISPC · Form: 8-K · Filed: Nov 3, 2025 · CIK: 1558569
Sentiment: neutral
Filing Stats: 850 words · 3 min read · ~3 pages · Grade level 11.9 · Accepted 2025-11-03 09:00:25
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share ISPC The Nasdaq Stock Mar
Filing Documents
- ea0263543-8k_ispecimen.htm (8-K) — 38KB
- 0001213900-25-104942.txt ( ) — 203KB
- ispc-20251030.xsd (EX-101.SCH) — 3KB
- ispc-20251030_lab.xml (EX-101.LAB) — 33KB
- ispc-20251030_pre.xml (EX-101.PRE) — 22KB
- ea0263543-8k_ispecimen_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On October 30, 2025, iSpecimen Inc. (the "Company") held a special meeting of stockholders (the "Special Meeting"). As of the close of business on July 25, 2025, the record date for the Special Meeting, there were 3,979,517 shares of the Company's common stock outstanding and entitled to vote. A total of 1,437,502 shares were present in person or represented by proxy, constituting approximately 36% of the shares outstanding and entitled to vote and therefore representing a quorum. The proposals submitted to the stockholders at the Special Meeting are described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on October 14, 2025. The final voting results for each proposal are set forth below. 1. Approval of Reverse Stock Split To approve an amendment to the Company's Fourth Amended and Restated Certificate of Incorporation (the "Charter") to effect a reverse stock split of the Company's common stock at a ratio in a range of one-for-ten (1:10) to one-for-one hundred (1:100), with the exact ratio to be determined by the Board of Directors (the "Board") at its discretion. FOR AGAINST ABSTAIN BROKER NON-VOTE 1,387,412 43,787 6,303 0 Proposal 1 was approved. 2. Approval of Increase in Authorized Shares To approve an amendment to the Charter to increase the total number of authorized shares of capital stock from 250,000,000 to 1,000,000,000. FOR AGAINST ABSTAIN BROKER NON-VOTE 1,370,770 56,782 9,950 0 Proposal 2 was approved. 3. Approval Pursuant to Nasdaq Listing Rule 5635(d) - Private Financing Transactions To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of common stock (and/or securities convertible into or exercisable for common stock) in one or more private financing transactions, potentially exceeding 19.99% of the outstanding shares or voting power and a